$26.50
2.068.41%
Pre-Market: Feb 6, 7:00 AM EDT
Fidelity Disruptive Medicine ETF (NASDAQ: FMED)
Ticker | Name | Share % | |
---|---|---|---|
BSX | Boston Scientific Corp | 6.60% | |
ALNY | Alnylam Pharmaceuticals | 5.17% | |
UNH | Unitedhealth Group Inc | 4.28% | |
ISRG | Intuitive Surgical Inc | 3.96% | |
DHR | Danaher Corp | 3.67% | |
PODD | Insulet Corp | 3.61% | |
CNC | Centene Corp | 3.15% | |
REGN | Regeneron Pharmaceuticals Inc Common Stock Usd | 2.76% | |
LLY | Eli Lilly And Co | 2.68% | |
SYK | Stryker Corp | 2.59% |
The FMED ETF is currently trading at $26.50, which represents a 8.41% change. Over the past 52 weeks, the ETF has traded as high as $26.79 and as low as $23.32.
The expense ratio of FMED is 0.5%. This represents the annual fee that all funds or ETFs charge their shareholders.
The total Assets Under Management (AUM) for FMED is 52.50M. This represents the total market value of the assets managed by the ETF.
FMED follows a Large Cap Blend investment style.
The top holdings of FMED include: BSX (6.6%), ALNY (5.17%), UNH (4.28%), ISRG (3.96%), DHR (3.67%). These represent the largest positions in the ETF's portfolio.
Average daily volume data for FMED is currently not available.